SRPT Sarepta Therapeutics Inc

USD 130.23 1.98 1.54386
Icon

Sarepta Therapeutics Inc (SRPT) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 130.23

+1.98 (+1.54)%

USD 11.97B

0.59M

USD 146.79(+12.72%)

USD 127.80 (-1.87%)

Icon

SRPT

Sarepta Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 130.23
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 11.97B

USD 127.80 (-1.87%)

USD 130.23

Sarepta Therapeutics Inc (SRPT) Stock Forecast

Show ratings and price targets of :
USD 146.79
(+12.72%)

Based on the Sarepta Therapeutics Inc stock forecast from 13 analysts, the average analyst target price for Sarepta Therapeutics Inc is USD 146.79 over the next 12 months. Sarepta Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Sarepta Therapeutics Inc is Slightly Bearish, which is based on 3 positive signals and 4 negative signals. At the last closing, Sarepta Therapeutics Inc’s stock price was USD 130.23. Sarepta Therapeutics Inc’s stock price has changed by +3.29% over the past week, -7.98% over the past month and -0.69% over the last year.

No recent analyst target price found for Sarepta Therapeutics Inc
No recent average analyst rating found for Sarepta Therapeutics Inc

Company Overview Sarepta Therapeutics Inc

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat du...Read More

https://www.sarepta.com

215 First Street, Cambridge, MA, United States, 02142

1,314

December

USD

USA

Adjusted Closing Price for Sarepta Therapeutics Inc (SRPT)

Loading...

Unadjusted Closing Price for Sarepta Therapeutics Inc (SRPT)

Loading...

Share Trading Volume for Sarepta Therapeutics Inc Shares

Loading...

Compare Performance of Sarepta Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for SRPT

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Sarepta Therapeutics Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -1.14 (-0.27%) USD107.38B 29.93 21.06

ETFs Containing SRPT

Symbol Name SRPT's Weight Expense Ratio Price(Change) Market Cap
PINK
Simplify Exchange Traded .. 8.88 % 0.50 % +0.56 (+1.85%) USD0.13B

Frequently Asked Questions About Sarepta Therapeutics Inc (SRPT) Stock

Based on ratings from 13 analysts Sarepta Therapeutics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 17 buy, sell and 3 hold ratings.

Unfortunately we do not have enough data on SRPT's stock to indicate if its a good dividend stock.

Based on targets from 13 analysts, the average taret price for SRPT is USD 146.79 over the next 12 months. The maximum analyst target price is USD 224 while the minimum anlayst target price is USD 40.

Unfortunately we do not have enough data on SRPT's stock to indicate if its overvalued.

The last closing price of SRPT's stock was USD 130.23.

The most recent market capitalization for SRPT is USD 11.97B.

Based on targets from 13 analysts, the average taret price for SRPT is projected at USD 146.79 over the next 12 months. This means that SRPT's stock price may go up by +12.72% over the next 12 months.

Following are ETFs with the highest allocation to Sarepta Therapeutics Inc's stock :

PINK

As per our most recent records Sarepta Therapeutics Inc has 1,314 Employees.

Sarepta Therapeutics Inc's registered address is 215 First Street, Cambridge, MA, United States, 02142. You can get more information about it from Sarepta Therapeutics Inc's website at https://www.sarepta.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...